G0800247/MRC_/Medical Research Council/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2009	8
2010	7
2011	13
2012	11
2013	16
2014	14
2015	23
2016	11
2017	6
2024	0

1

Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research.

McIlleron H, Abdel-Rahman S, Dave JA, Blockman M, Owen A. McIlleron H, et al. J Infect Dis. 2015 Jun 15;211 Suppl 3(Suppl 3):S115-25. doi: 10.1093/infdis/jiu600. J Infect Dis. 2015. PMID: 26009615 Free PMC article. Review.

2

The role of drug transporters in the kidney: lessons from tenofovir.

Moss DM, Neary M, Owen A. Moss DM, et al. Front Pharmacol. 2014 Nov 11;5:248. doi: 10.3389/fphar.2014.00248. eCollection 2014. Front Pharmacol. 2014. PMID: 25426075 Free PMC article. Review.

3

Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.

Tatham LM, Rannard SP, Owen A. Tatham LM, et al. Ther Deliv. 2015;6(4):469-90. doi: 10.4155/tde.15.4. Ther Deliv. 2015. PMID: 25996045 Review.

4

New approaches to antiretroviral drug delivery: challenges and opportunities associated with the use of long-acting injectable agents.

Boffito M, Jackson A, Owen A, Becker S. Boffito M, et al. Drugs. 2014 Jan;74(1):7-13. doi: 10.1007/s40265-013-0163-7. Drugs. 2014. PMID: 24327298 Review.

5

Nanomedicines for HIV therapy.

Siccardi M, Martin P, McDonald TO, Liptrott NJ, Giardiello M, Rannard S, Owen A. Siccardi M, et al. Ther Deliv. 2013 Feb;4(2):153-6. doi: 10.4155/tde.12.156. Ther Deliv. 2013. PMID: 23343155

6

Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro.

Roberts O, Khoo S, Owen A, Siccardi M. Roberts O, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e01776-16. doi: 10.1128/AAC.01776-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28193650 Free PMC article.

7

Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics.

Olagunju A, Bolaji O, Amara A, Else L, Okafor O, Adejuyigbe E, Oyigboja J, Back D, Khoo S, Owen A. Olagunju A, et al. Clin Pharmacol Ther. 2015 Mar;97(3):298-306. doi: 10.1002/cpt.43. Epub 2015 Jan 20. Clin Pharmacol Ther. 2015. PMID: 25669165

8

Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.

Nelson AG, Zhang X, Ganapathi U, Szekely Z, Flexner CW, Owen A, Sinko PJ. Nelson AG, et al. J Control Release. 2015 Dec 10;219:669-680. doi: 10.1016/j.jconrel.2015.08.042. Epub 2015 Aug 24. J Control Release. 2015. PMID: 26315816 Free PMC article. Review.

9

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.

Olagunju A, Owen A, Cressey TR. Olagunju A, et al. Pharmacogenomics. 2012 Oct;13(13):1501-22. doi: 10.2217/pgs.12.138. Pharmacogenomics. 2012. PMID: 23057550 Review.

10

The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes.

Janneh O, Owen A, Bray PG, Back DJ, Pirmohamed M. Janneh O, et al. Br J Pharmacol. 2010 Jan 1;159(2):484-93. doi: 10.1111/j.1476-5381.2009.00552.x. Epub 2009 Dec 10. Br J Pharmacol. 2010. PMID: 20015290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year